Quinlan Amy
SEC CIK 2027706 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| VOR | Vor Biopharma Inc. | VP of Fin | 50.3K | — | — | 3 | 2024-08-01 | 2024-11-06 |
Most active insiders at VOR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | RA CAPITAL MANAGEMENT, L.P. | Dir, 10% | — | $55.62M |
| 2 | Reprogrammed Interchange LLC | 10% | — | $15.80M |
| 3 | Shah Rajeev M. | Dir, 10% | — | $13.71M |
| 4 | Kolchinsky Peter | Dir, 10% | — | $10.37M |
| 5 | RA Capital Nexus Fund, L.P. | Dir | — | $3.43M |
| 6 | Mahatme Sandesh | CFO | — | — |
Quinlan Amy made no open-market trades at VOR in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-11-08 | 2024-11-06 | VOR | Vor Biopharma Inc. | Quinlan Amy | VP of Fin | F - Tax | $0.86 | -206 | 50.3K | -0.4% | -$177.16 | |
| 2024-11-05 | 2024-11-01 | VOR | Vor Biopharma Inc. | Quinlan Amy | VP of Fin | F - Tax | $0.8 | -343 | 50.5K | -0.7% | -$274.40 | |
| M | 2024-09-04 | 2024-08-01+ | VOR | Vor Biopharma Inc. | Quinlan Amy | VP of Fin | F - Tax | $0.8393 | -4,951 | 55.5K | -8% | -$4,155 |
Purchase Sale Sale after option exercise All abbreviations